Logo image of CLVT

CLARIVATE PLC (CLVT) Stock Fundamental Analysis

USA - NYSE:CLVT - JE00BJJN4441 - Common Stock

3.58 USD
+0.03 (+0.85%)
Last: 10/17/2025, 8:04:00 PM
3.58 USD
0 (0%)
After Hours: 10/17/2025, 8:04:00 PM
Fundamental Rating

3

Overall CLVT gets a fundamental rating of 3 out of 10. We evaluated CLVT against 82 industry peers in the Professional Services industry. CLVT has a bad profitability rating. Also its financial health evaluation is rather negative. CLVT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

CLVT had positive earnings in the past year.
CLVT had a positive operating cash flow in the past year.
In the past 5 years CLVT always reported negative net income.
CLVT had a positive operating cash flow in each of the past 5 years.
CLVT Yearly Net Income VS EBIT VS OCF VS FCFCLVT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B -4B

1.2 Ratios

CLVT has a worse Return On Assets (-3.79%) than 69.51% of its industry peers.
Looking at the Return On Equity, with a value of -8.68%, CLVT is doing worse than 68.29% of the companies in the same industry.
CLVT's Return On Invested Capital of 1.67% is on the low side compared to the rest of the industry. CLVT is outperformed by 64.63% of its industry peers.
CLVT had an Average Return On Invested Capital over the past 3 years of 1.87%. This is significantly below the industry average of 13.40%.
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROIC 1.67%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
CLVT Yearly ROA, ROE, ROICCLVT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40

1.3 Margins

CLVT has a Operating Margin of 8.41%. This is in the better half of the industry: CLVT outperforms 67.07% of its industry peers.
CLVT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 66.07%, CLVT is in the better half of the industry, outperforming 79.27% of the companies in the same industry.
In the last couple of years the Gross Margin of CLVT has remained more or less at the same level.
Industry RankSector Rank
OM 8.41%
PM (TTM) N/A
GM 66.07%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
CLVT Yearly Profit, Operating, Gross MarginsCLVT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

0

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CLVT is destroying value.
CLVT has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CLVT has more shares outstanding
The debt/assets ratio for CLVT is higher compared to a year ago.
CLVT Yearly Shares OutstandingCLVT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
CLVT Yearly Total Debt VS Total AssetsCLVT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

CLVT has an Altman-Z score of -0.43. This is a bad value and indicates that CLVT is not financially healthy and even has some risk of bankruptcy.
CLVT's Altman-Z score of -0.43 is on the low side compared to the rest of the industry. CLVT is outperformed by 85.37% of its industry peers.
The Debt to FCF ratio of CLVT is 13.65, which is on the high side as it means it would take CLVT, 13.65 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 13.65, CLVT is doing worse than 60.98% of the companies in the same industry.
A Debt/Equity ratio of 0.90 indicates that CLVT is somewhat dependend on debt financing.
CLVT's Debt to Equity ratio of 0.90 is on the low side compared to the rest of the industry. CLVT is outperformed by 67.07% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Altman-Z -0.43
ROIC/WACC0.23
WACC7.15%
CLVT Yearly LT Debt VS Equity VS FCFCLVT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

CLVT has a Current Ratio of 0.91. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
CLVT has a worse Current ratio (0.91) than 78.05% of its industry peers.
CLVT has a Quick Ratio of 0.91. This is a bad value and indicates that CLVT is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of CLVT (0.91) is worse than 78.05% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.91
CLVT Yearly Current Assets VS Current LiabilitesCLVT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

4

3. Growth

3.1 Past

The earnings per share for CLVT have decreased by -7.69% in the last year.
CLVT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 1.87% yearly.
CLVT shows a decrease in Revenue. In the last year, the revenue decreased by -3.92%.
The Revenue has been growing by 21.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%

3.2 Future

Based on estimates for the next years, CLVT will show a small growth in Earnings Per Share. The EPS will grow by 0.12% on average per year.
Based on estimates for the next years, CLVT will show a small growth in Revenue. The Revenue will grow by 0.76% on average per year.
EPS Next Y-10.74%
EPS Next 2Y-3.26%
EPS Next 3Y1.86%
EPS Next 5Y0.12%
Revenue Next Year-6.64%
Revenue Next 2Y-3.48%
Revenue Next 3Y-1.6%
Revenue Next 5Y0.76%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CLVT Yearly Revenue VS EstimatesCLVT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B 2.5B
CLVT Yearly EPS VS EstimatesCLVT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 4.97, the valuation of CLVT can be described as very cheap.
Based on the Price/Earnings ratio, CLVT is valued cheaply inside the industry as 97.56% of the companies are valued more expensively.
CLVT's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.40.
A Price/Forward Earnings ratio of 5.17 indicates a rather cheap valuation of CLVT.
Based on the Price/Forward Earnings ratio, CLVT is valued cheaply inside the industry as 95.12% of the companies are valued more expensively.
The average S&P500 Price/Forward Earnings ratio is at 22.94. CLVT is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.97
Fwd PE 5.17
CLVT Price Earnings VS Forward Price EarningsCLVT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

90.24% of the companies in the same industry are more expensive than CLVT, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CLVT indicates a rather cheap valuation: CLVT is cheaper than 89.02% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 7.27
EV/EBITDA 6.88
CLVT Per share dataCLVT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.26%
EPS Next 3Y1.86%

0

5. Dividend

5.1 Amount

No dividends for CLVT!.
Industry RankSector Rank
Dividend Yield N/A

CLARIVATE PLC

NYSE:CLVT (10/17/2025, 8:04:00 PM)

After market: 3.58 0 (0%)

3.58

+0.03 (+0.85%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)07-30 2025-07-30/bmo
Earnings (Next)10-29 2025-10-29/bmo
Inst Owners58.99%
Inst Owner ChangeN/A
Ins Owners0.86%
Ins Owner Change-1.57%
Market Cap2.41B
Analysts73.75
Price Target5.2 (45.25%)
Short Float %10.56%
Short Ratio9.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.06
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)10.04%
Min EPS beat(2)1.75%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)5.47%
Min EPS beat(4)0.21%
Max EPS beat(4)18.32%
EPS beat(8)7
Avg EPS beat(8)6.13%
EPS beat(12)11
Avg EPS beat(12)8.6%
EPS beat(16)15
Avg EPS beat(16)8.34%
Revenue beat(2)2
Avg Revenue beat(2)2.7%
Min Revenue beat(2)2.04%
Max Revenue beat(2)3.36%
Revenue beat(4)2
Avg Revenue beat(4)-0.24%
Min Revenue beat(4)-4.81%
Max Revenue beat(4)3.36%
Revenue beat(8)3
Avg Revenue beat(8)-0.62%
Revenue beat(12)4
Avg Revenue beat(12)-0.83%
Revenue beat(16)4
Avg Revenue beat(16)-1.28%
PT rev (1m)0%
PT rev (3m)-3.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.02%
EPS NY rev (1m)-1.13%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.25%
Valuation
Industry RankSector Rank
PE 4.97
Fwd PE 5.17
P/S 0.96
P/FCF 7.27
P/OCF 3.81
P/B 0.48
P/tB N/A
EV/EBITDA 6.88
EPS(TTM)0.72
EY20.11%
EPS(NY)0.69
Fwd EY19.34%
FCF(TTM)0.49
FCFY13.76%
OCF(TTM)0.94
OCFY26.25%
SpS3.72
BVpS7.43
TBVpS-7.23
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.79%
ROE -8.68%
ROCE 2.12%
ROIC 1.67%
ROICexc 1.74%
ROICexgc N/A
OM 8.41%
PM (TTM) N/A
GM 66.07%
FCFM 13.24%
ROA(3y)-14.17%
ROA(5y)-9.23%
ROE(3y)-29.57%
ROE(5y)-18.95%
ROIC(3y)1.87%
ROIC(5y)1.34%
ROICexc(3y)1.93%
ROICexc(5y)1.38%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.36%
ROCE(5y)1.69%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y62.12%
ROICexc growth 5Y45.61%
OM growth 3Y19.56%
OM growth 5Y51.34%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.32%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0.9
Debt/FCF 13.65
Debt/EBITDA 4.76
Cap/Depr 40.65%
Cap/Sales 12.02%
Interest Coverage 250
Cash Conversion 66.51%
Profit Quality N/A
Current Ratio 0.91
Quick Ratio 0.91
Altman-Z -0.43
F-Score6
WACC7.15%
ROIC/WACC0.23
Cap/Depr(3y)37.07%
Cap/Depr(5y)34.15%
Cap/Sales(3y)10.18%
Cap/Sales(5y)9.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.69%
EPS 3Y1.87%
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y-10.74%
EPS Next 2Y-3.26%
EPS Next 3Y1.86%
EPS Next 5Y0.12%
Revenue 1Y (TTM)-3.92%
Revenue growth 3Y10.85%
Revenue growth 5Y21.28%
Sales Q2Q%-4.44%
Revenue Next Year-6.64%
Revenue Next 2Y-3.48%
Revenue Next 3Y-1.6%
Revenue Next 5Y0.76%
EBIT growth 1Y-19.21%
EBIT growth 3Y32.53%
EBIT growth 5Y83.55%
EBIT Next Year9478.18%
EBIT Next 3Y362.33%
EBIT Next 5Y154.38%
FCF growth 1Y-31.45%
FCF growth 3Y16.61%
FCF growth 5Y48.48%
OCF growth 1Y-14.01%
OCF growth 3Y25.93%
OCF growth 5Y40.62%